Mark Hemingway

Mark Hemingway reports on the key institutions shaping public life, from lobbying groups to federal agencies to elections, for RealClearInvestigations. His writing has appeared in USA Today, Wall Street Journal, MTV.com, and The Weekly Standard.

For media inquiries, please contact media@realclear.com.

Author Archive

  • Sep 12, 2023
    Update, Aug. 29, 2023: 10 Drugs Face Medicare Price Negotiations, CNBC By Mark Hemingway, RealClearInvestigationsDecember 27, 2022 President Biden has promised that the $740 billion...